[144] CoreWeave, Inc. SEC Filing

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) Form 144 — An authorized sale notice reports an intended sale of 14,615 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $2,000,062.75, and an approximate sale date of 10/01/2025 on NASDAQ. The shares were acquired as Founders Shares on 12/27/2023. The filing shows total outstanding shares of 370,470,348, placing the planned sale at a small fraction of outstanding stock. The document also lists multiple recent sales by related parties and entities during August–September 2025, including several 10b5-1 plan transactions and substantial gross proceeds reported.

Positive

• Transparency: The filing discloses the broker (Morgan Stanley Smith Barney LLC), acquisition date (12/27/2023), and nature of the shares (Founders Shares).
• Rule 10b5-1 usage disclosed: Multiple prior sales are clearly labeled as 10b5-1 plan transactions, indicating planned, pre-arranged dispositions.

Negative

• Insider/affiliate selling activity: Several large sales during Aug–Sep 2025 produced substantial gross proceeds, which could raise investor attention about insider liquidity.
• Concentration of prior sales: Multiple sizable disposals by related parties (e.g., West Clay Capital LLC) in a short period are reported.

Insights

Securities Analyst

TL;DR Insider sale notice for 14,615 shares valued at ~$2.0M; prior 10b5-1 sales indicate ongoing disposition activity.

The Form 144 notifies the SEC and market that an insider or restricted holder intends to sell 14,615 common shares via Morgan Stanley Smith Barney LLC with an aggregate market value of $2,000,062.75 and an approximate sale date of October 1, 2025. The shares were acquired as founders shares on December 27, 2023. The filing also discloses several sizable sales by related parties and trusts during August and September 2025, many labelled as 10b5-1 plan sales, producing multi-million dollar gross proceeds. For investors, this is a routine disclosure of planned insider sales rather than operational or financial performance information.

Corporate Governance Specialist

TL;DR Disclosure is compliant and details both the proposed sale and recent affiliated 10b5-1 transactions.

The submission provides required detail on the nature and origin of the shares (founders shares acquired 12/27/2023) and identifies the broker and intended exchange. It also lists multiple prior dispositions by individuals and entities, notably several 10b5-1 plan sales with significant gross proceeds in August–September 2025. This supports transparency about insider liquidity events and adherence to rule-based sale plans. The document contains the standard representation that the seller is not aware of undisclosed material adverse information.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	14615	2000062.75	370470348	10/01/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/27/2023	Founders Shares	Issuer			14615	12/27/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
BRIAN VENTURO 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/30/2025	65593	9146287.92
10b5-1 Sales for WEST CLAY CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/17/2025	281250	33379846.88
10b5-1 Sales for WEST CLAY CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/03/2025	281250	25487803.13
10b5-1 Sales for YOLO APV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	19410	1808187.08
10b5-1 Sales for YOLO ECV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	19410	1808187.08
10b5-1 Sales for WEST CLAY CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/20/2025	281250	24777421.88
10b5-1 Sales for YOLO APV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/20/2025	21531	1896827.27
10b5-1 Sales for YOLO ECV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/20/2025	21531	1896827.27

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CoreWeave's (CRWV) Form 144 report?

The Form 144 reports an intended sale of 14,615 common shares valued at $2,000,062.75, to be sold approximately on 10/01/2025 through Morgan Stanley Smith Barney LLC on NASDAQ.

When were the shares to be sold by the filer acquired?

The shares were acquired as Founders Shares on 12/27/2023.

How many shares does CoreWeave have outstanding according to the filing?

The filing lists 370,470,348 shares outstanding.

Does the filing show recent related-party sales?

Yes. The filing lists multiple sales in Aug–Sep 2025 by individuals and entities, many under 10b5-1 plans, with gross proceeds in the multi‑million dollar range.

Which broker will handle the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, New York, NY.